Federal Register Notice: FDA is establishing a public docket for comment on the agency’s blood donor deferral recommendations for reducing the risk of human immunodeficiency virus (HIV) transmission as described in the document entitled Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Guidance for Industry dated 12/2015. Comments should be submitted by 11/25. To view this notice, click here.
